These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22742816)

  • 1. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
    Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V
    Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
    Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
    Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
    Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
    Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
    Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
    Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
    Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
    Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT antagonist, SFRP1, is Hedgehog signaling target.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Jan; 17(1):171-5. PubMed ID: 16328026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Hypermethylation of
    Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
    Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic dysregulation of secreted Frizzled-related proteins in multiple myeloma.
    Jost E; Gezer D; Wilop S; Suzuki H; Herman JG; Osieka R; Galm O
    Cancer Lett; 2009 Aug; 281(1):24-31. PubMed ID: 19299079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
    Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
    Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of a negative regulation system for canonical WNT signaling pathway by the Notch-DKK2 signaling loop in primates.
    Katoh M; Katoh M
    Int J Mol Med; 2007 Jan; 19(1):197-201. PubMed ID: 17143565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.